Tribe Technologies
Trending >

Profound Medical is profoundly undervalued, says Echelon Wealth

Profound Medical

Profound MedicalA quarter that simply met his expectations isn’t shaking Echelon Wealth Partners analyst Doug Loe’s conviction that Profound Medical (Profound Medical Stock Quote, Chart, News: TSXV:PRN) is extremely undervalued.

Yesterday, Profound Medical reported its Q1 2017 results. The company lost $4.11-million on revenue of $591,517.

“The first quarter of 2017 represents a transformative period in Profound’s history, and builds on the momentum we established in 2016,” said CEO Dr. Arun Menawat. “Not only did the company record revenue for the first time, but we also announced the first Tulsa-Pro-paid procedure in Germany and our entry into the Finnish market. Taken together, these milestones demonstrate the growing interest in the Tulsa-Pro procedure as an attractive option for patients with localized prostate cancer. We look forward to updating our stakeholders as we progress.”

Loe notes that Profound’s first revenue ever came from new capital equipment sales in Europe for its flagship MRguided high-intensity frequency ultrasound prostate ablation platform TULSA-PRO, which is already CE Marked. He says it is still early days for TULSA-PRO’s commercial ramp in the EU, but says he sees positive signs in a growing install base, especially considering the potential impact of partnerships with Siemens and Philips.


“We believe Profound can generate value both through EU commercial traction (and through the growing positive case history that clinical use of commercial devices should generate) and through advancing TACT to data next year,” says Loe.

In a research update to clients today, Loe maintained his “Buy” rating and one-year target price of $4.00 on Profound Medical, implying a return of 344 per cent at the time of publication.

Loe thinks Profound Medical will post EBITDA of negative $15.5-million on revenue of $3.28-million in fiscal 2017. He expects these numbers will improve to EBITDA of negative $12.1-million on a topline of $9.8-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

About The Author /

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
insta twitter facebook


Leave a Reply